(EXO) Exor - Ratings and Ratios
Automotive, Agriculture, Construction, Sports, Trucks, Powertrain
EXO EPS (Earnings per Share)
EXO Revenue
Description: EXO Exor
Exor N.V. is a multinational conglomerate with a diverse portfolio of businesses across various industries, including automotive, agriculture, construction, sports cars, and more. The company operates through several segments, including Ferrari, Stellantis, CNH Industrial, Iveco Group, Juventus, and GEDI, offering a wide range of products and services such as luxury sports cars, automotive vehicles, mobility solutions, agricultural and construction equipment, powertrain technologies, and financing services.
Some key aspects of Exor N.V.s business include its ownership of iconic brands like Ferrari and Juventus, as well as its significant presence in the automotive industry through its stakes in Stellantis and other companies. The companys diverse portfolio also includes publishing, healthcare, and real estate businesses. With a market capitalization of approximately €29.7 billion, Exor N.V. is a significant player in the global economy.
From a financial perspective, Exor N.V.s Return on Equity (RoE) of 13.63% indicates a relatively strong ability to generate profits from shareholder equity. However, its Price-to-Earnings (P/E) ratio of 1.31 is unusually low, suggesting that the stock may be undervalued or that the company is facing significant challenges. Further analysis of the companys financial statements and industry trends would be necessary to understand the underlying drivers of these metrics.
In terms of key performance indicators (KPIs), Exor N.V.s financial performance can be evaluated using metrics such as revenue growth, operating margin, and debt-to-equity ratio. The companys diversified portfolio and significant presence in various industries make it an interesting case study for investors and analysts. With a strong brand portfolio and global reach, Exor N.V. is well-positioned to capitalize on emerging trends and opportunities in its various markets.
EXO Stock Overview
| Market Cap in USD | 32,434m |
| Sub-Industry | Automobile Manufacturers |
| IPO / Inception |
EXO Stock Ratings
| Growth Rating | 3.07% |
| Fundamental | 73.5% |
| Dividend Rating | 38.8% |
| Return 12m vs S&P 500 | -29.1% |
| Analyst Rating | - |
EXO Dividends
| Dividend Yield 12m | 0.57% |
| Yield on Cost 5y | 0.75% |
| Annual Growth 5y | 2.25% |
| Payout Consistency | 100.0% |
| Payout Ratio | 0.7% |
EXO Growth Ratios
| Growth Correlation 3m | -35.2% |
| Growth Correlation 12m | -73.9% |
| Growth Correlation 5y | 64.3% |
| CAGR 5y | 8.38% |
| CAGR/Max DD 3y | 0.29 |
| CAGR/Mean DD 3y | 1.46 |
| Sharpe Ratio 12m | -0.19 |
| Alpha | 0.00 |
| Beta | 0.851 |
| Volatility | 18.28% |
| Current Volume | 186.4k |
| Average Volume 20d | 136.4k |
| Stop Loss | 79.3 (-3.1%) |
| Signal | -1.21 |
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (4.19b TTM) > 0 and > 6% of Revenue (6% = 2.68b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 5.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.67% (prev 84.23%; Δ -85.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 6.25b > Net Income 4.19b (YES >=105%, WARN >=100%) |
| Net Debt (3.94b) to EBITDA (6.43b) ratio: 0.61 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (213.7m) change vs 12m ago -7.13% (target <= -2.0% for YES) |
| Gross Margin 25.27% (prev 22.72%; Δ 2.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.81% (prev 46.75%; Δ 21.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 46.80 (EBITDA TTM 6.43b / Interest Expense TTM 113.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.18
| (A) -0.02 = (Total Current Assets 339.0m - Total Current Liabilities 1.09b) / Total Assets 42.46b |
| (B) 0.35 = Retained Earnings (Balance) 14.67b / Total Assets 42.46b |
| (C) 0.08 = EBIT TTM 5.29b / Avg Total Assets 65.98b |
| (D) 3.45 = Book Value of Equity 14.67b / Total Liabilities 4.25b |
| Total Rating: 5.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.47
| 1. Piotroski 9.0pt = 4.0 |
| 2. FCF Yield 10.95% = 5.0 |
| 3. FCF Margin 7.68% = 1.92 |
| 4. Debt/Equity 0.11 = 2.49 |
| 5. Debt/Ebitda 0.64 = 2.19 |
| 6. ROIC - WACC (= 1.07)% = 1.33 |
| 7. RoE 13.63% = 1.14 |
| 8. Rev. Trend 71.87% = 5.39 |
| 9. EPS Trend 0.12% = 0.01 |
What is the price of EXO shares?
Over the past week, the price has changed by -1.86%, over one month by -6.94%, over three months by +0.12% and over the past year by -15.91%.
Is Exor a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXO is around 74.28 EUR . This means that EXO is currently overvalued and has a potential downside of -9.25%.
Is EXO a buy, sell or hold?
What are the forecasts/targets for the EXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.8 | 45.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 82.7 | 1% |
EXO Fundamental Data Overview
Market Cap EUR = 27.45b (27.45b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 153.0m EUR (Cash only, last quarter)
P/E Trailing = 1.253
P/S = 1.783
P/B = 0.4427
Beta = 0.401
Revenue TTM = 44.74b EUR
EBIT TTM = 5.29b EUR
EBITDA TTM = 6.43b EUR
Long Term Debt = 3.04b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.05b EUR (from shortLongTermDebt, last quarter)
Debt = 4.09b EUR (Calculated: Short Term 1.05b + Long Term 3.04b)
Net Debt = 3.94b EUR (from netDebt column, last quarter)
Enterprise Value = 31.39b EUR (27.45b + Debt 4.09b - CCE 153.0m)
Interest Coverage Ratio = 46.80 (Ebit TTM 5.29b / Interest Expense TTM 113.0m)
FCF Yield = 10.95% (FCF TTM 3.44b / Enterprise Value 31.39b)
FCF Margin = 7.68% (FCF TTM 3.44b / Revenue TTM 44.74b)
Net Margin = 9.37% (Net Income TTM 4.19b / Revenue TTM 44.74b)
Gross Margin = 25.27% ((Revenue TTM 44.74b - Cost of Revenue TTM 33.43b) / Revenue TTM)
Tobins Q-Ratio = 2.14 (Enterprise Value 31.39b / Book Value Of Equity 14.67b)
Interest Expense / Debt = 2.76% (Interest Expense 113.0m / Debt 4.09b)
Taxrate = 12.89% (243.5m / 1.89b)
NOPAT = 4.61b (EBIT 5.29b * (1 - 12.89%))
Current Ratio = 0.31 (Total Current Assets 339.0m / Total Current Liabilities 1.09b)
Debt / Equity = 0.11 (Debt 4.09b / last Quarter total Stockholder Equity 38.21b)
Debt / EBITDA = 0.64 (Net Debt 3.94b / EBITDA 6.43b)
Debt / FCF = 1.19 (Debt 4.09b / FCF TTM 3.44b)
Total Stockholder Equity = 30.77b (last 4 quarters mean)
RoA = 9.88% (Net Income 4.19b, Total Assets 42.46b )
RoE = 13.63% (Net Income TTM 4.19b / Total Stockholder Equity 30.77b)
RoCE = 15.64% (Ebit 5.29b / (Equity 30.77b + L.T.Debt 3.04b))
RoIC = 9.34% (NOPAT 4.61b / Invested Capital 49.30b)
WACC = 8.28% (E(27.45b)/V(31.54b) * Re(9.15%)) + (D(4.09b)/V(31.54b) * Rd(2.76%) * (1-Tc(0.13)))
Shares Correlation 3-Years: -6.36 | Cagr: -0.25%
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.45% ; FCFE base≈3.05b ; Y1≈2.16b ; Y5≈1.15b
Fair Price DCF = 91.39 (DCF Value 18.42b / Shares Outstanding 201.5m; 5y FCF grow -34.29% → 3.0% )
EPS Correlation: 0.12 | EPS CAGR: 1092 % | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.87 | Revenue CAGR: 13.66% | SUE: 0.0 | # QB: 0